Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYTropical medicine and infectious disease

Low Prevalence of HIV-1 Antiretroviral Resistance Among Patients Experiencing Virological Failure on Dolutegravir-Based Regimens: A Prospective Cohort Study in Bunia, Democratic Republic of the Congo

  • Alex Liripa Kwendra1
  • Augustin Mouinga-Ondeme2
  • Jéordy Dimitri Engone-Ondo2
  • Herman Chelo Ngadjole3
  • Otniel Adjala-Ondeme2
  • Oloumbou Fedricksen Eldridge2
  • Salomon Batina Agasa4
  • Ivan S. Mfouo-Tynga2
4 affiliations
  1. 1Département de Médecine Interne, Infectiologie Tropicale, Faculté de Médecine, Université de Bunia, Bunia 292, Democratic Republic of the Congo;
  2. 2Unité des Infections Rétrovirales et Pathologies Associées, (CIRMF), Franceville P.O. Box 769, Gabon; (A.M.-O.); (J.D.E.-O.); (O.A.-O.); (O.F.E.)
  3. 3Département de la Santé Publique, , Goma 2204, Democratic Republic of the Congo;
  4. 4Département de Médecine Interne, , Kisangani 2012, Democratic Republic of the Congo;
Read full textPDFCite

Related

  1. Who is not benefitting from contemporary antiretroviral therapy? Correlates of virological non suppression among people with HIV accessing care in a Boston community health center
    Abigail W. Batchelder, Jacklyn Foley, Surabhi Iyer +2
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  2. Burden and determinants of hyperglycaemia and dyslipidaemia in Zimbabwean adults living with HIV on dolutegravir-based first-line antiretroviral therapy: A cross-sectional study
    Ratidzo Chirimo, Danai Tavonga Zhou, Tinashe Mudzviti +6
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyMicrobiologyPLOS
  3. Risk factors for low-level viremia and virological failure in HIV patients in southwestern China who transitioned to second-line antiretroviral therapy after failure of first-line treatment: a retrospective cohort study
    Zongyu Nie, Yan Zheng, Liuying Yang +3
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefEurope PMC
  4. Prevalence and determinants of virological non-suppression at 24 weeks among people living with HIV in Hubei, China
    Ke Hong, Dingyuan Zhao, Jie Zheng +7
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  5. Prevalence of neural tube defects and major external structural abnormalities by antiretroviral treatment regimen in Botswana in 2014–22: a birth outcomes surveillance study
    Rebecca Zash, Modiegi Diseko, Lewis B Holmes +11
    The Lancet Global HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref

Cite

BibTeXRIS
BibTeX
@article{kwendra2026prevalence,
  title = {{Low Prevalence of HIV-1 Antiretroviral Resistance Among Patients Experiencing Virological Failure on Dolutegravir-Based Regimens: A Prospective Cohort Study in Bunia, Democratic Republic of the Congo}},
  author = {Alex Liripa Kwendra and Augustin Mouinga-Ondeme and Jéordy Dimitri Engone-Ondo and Herman Chelo Ngadjole and Otniel Adjala-Ondeme and Oloumbou Fedricksen Eldridge and Salomon Batina Agasa and Ivan S. Mfouo-Tynga},
  journal = {Tropical medicine and infectious disease},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13709768},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Low Prevalence of HIV-1 Antiretroviral Resistance Among Patients Experiencing Virological Failure on Dolutegravir-Based Regimens: A Prospective Cohort Study in Bunia, Democratic Republic of the Congo
AU  - Alex Liripa Kwendra
AU  - Augustin Mouinga-Ondeme
AU  - Jéordy Dimitri Engone-Ondo
AU  - Herman Chelo Ngadjole
AU  - Otniel Adjala-Ondeme
AU  - Oloumbou Fedricksen Eldridge
AU  - Salomon Batina Agasa
AU  - Ivan S. Mfouo-Tynga
PY  - 2026
DA  - 2026/10/01
JO  - Tropical medicine and infectious disease
UR  - https://europepmc.org/article/PMC/PMC13709768
SN  - 2414-6366
ER  -